ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 357 filers reported holding ISIS PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 1.83 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2015 | $70,000 | -97.3% | 1,741 | -96.1% | 0.00% | -100.0% |
Q2 2015 | $2,595,000 | -78.0% | 45,084 | -75.6% | 0.01% | -78.3% |
Q1 2015 | $11,784,000 | +52.2% | 185,081 | +47.6% | 0.02% | +43.8% |
Q4 2014 | $7,743,000 | +130.4% | 125,415 | +44.9% | 0.02% | +128.6% |
Q3 2014 | $3,361,000 | – | 86,566 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BB BIOTECH AG | 6,417,548 | $255,675,000 | 13.66% |
HWG Holdings LP | 339,799 | $13,538,000 | 8.73% |
DOWLING & YAHNKE LLC | 675,798 | $26,924,000 | 3.78% |
GARRISON BRADFORD & ASSOCIATES INC | 99,300 | $3,956,000 | 3.74% |
WILLIAM HARRIS INVESTORS INC | 283,834 | $11,308,000 | 3.35% |
SECTORAL ASSET MANAGEMENT INC | 1,222,401 | $48,700,000 | 2.10% |
AVALON CAPITAL MANAGEMENT | 49,999 | $1,992,000 | 1.68% |
PINNACLE ASSOCIATES LTD | 2,016,369 | $80,332,000 | 1.57% |
PERKINS CAPITAL MANAGEMENT INC | 48,515 | $1,933,000 | 1.30% |
NCM Capital Advisers, Inc. | 31,100 | $1,239,000 | 1.28% |